GSTM1 and lung cancer: Correlations between lung cancer risk and combinations of CYP1A1, GSTM1 and GSTT1 is of particular interest since these genotypes suggest that alterations in the action of phases I and II enzymes lead to defective metabolism of xenobiotic compounds, thereby potentiating the cancer risk.